CMV-IGIV: Phase III start

This month, NIH will begin a double-blind, placebo-controlled U.S. Phase III trial to evaluate IV

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE